Atrivity

MAY 5, 2021

The pharmaceutical and healthcare sector has been forced to change the way it connects, educates and engages with HCPs through new digital channels because of Covid-19. The days when a pharma rep can walk into any doctors' office at a specific time and expect to see the doctor if they were patient enough, could soon be a distant memory.

Sales 52

Sales Pharma Doctors Pharma Rep 52

Veeva

APRIL 7, 2022

This rose significantly to 332,881 by Q3 2021 as the pandemic continued. In Q4 2021 when some face-to-face interactions returned, the number reduced only to 289,511. True omnichannel planning means executing on all channels available to the reps, using a multi-faceted approach to maximise results.

Pharma Rep 40

Pharma Rep Pharma reps Pharma Customer Relationship Management 40

Veeva

AUGUST 22, 2021

The pandemic has changed the landscape for healthcare professional (HCP) engagement across India’s life sciences industry. Digital engagement is now more important than ever, as face-to-face (F2F) interactions between sales reps and HCPs literally stopped overnight. Emergence of digital. Will digital overshadow in person interactions?

Pharma 52

Pharma Pharma Rep Pharma reps Pharma sales reps 52

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. 2 The percentage of healthcare providers willing to see pharmaceutical company reps in person had declined from 67% in 2018 to 54% in 2019. Fierce Healthcare.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Veeva

FEBRUARY 6, 2022

According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1.

Pharma 52

Pharma Medical Consulting Patients 52